Clinical Trials Logo

Clinical Trial Summary

The study's main objective will be to assess which effect early initiated rehabilitation has on the frequency of complications and the level of physical and cognitive functioning after aneurysmal subarachnoid hemorrhage (SAH).

To this end the following aspects will be investigated:

The frequency of complications (with special emphasis on pulmonary complications,thromboembolic events, cerebral vasospasm, unintended discontinuation of drains and lines)

- Length of stay in hospitals and socio-economic impact

- Physical and cognitive function in the early and chronic phase after SAH

- Health-related quality of life and participation in society in the chronic phase


Clinical Trial Description

Oslo University Hospital (OUS) is the primary hospital for Health Region South-East regarding treatment of patients with SAH. Approximately 120 patients are referred annually. OUS,Rikshospitalet, Dept of Neurosurgery offers 24/7 service of surgical and vascular aneurysm repair performed by a dedicated vascular team.

Patients admitted in 2012 are treated in accordance to the standard institutional protocol plus an early rehabilitation model adapted to SAH, while patients admitted in 2011 who did not receive any early rehabilitation, but apart from that were treated identically, serve as a control group.

All patients admitted to the intermediate unit at OUS in 2011 and 2012 with aneurysmal SAH and repaired aneurysm will be invited to participate in this study. Examination of the patients from both 2011 and 2012 will be performed as part of routine, neurosurgical follow- up which is in the early phase at 3-6 months and in the chronic phase at least 12 months post SAH. Exclusion criteria for participation in the study: unsecured ruptured aneurysm, symptomatic aneurysm without rupture, previous SAH or brain injury, diagnosis of a neurodegenerative disorder, patients from other health regions or tourists, patients that were treated at the intensive care unit (ICU )only. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01656317
Study type Interventional
Source Oslo University Hospital
Contact
Status Completed
Phase N/A
Start date January 1, 2012
Completion date December 20, 2015

See also
  Status Clinical Trial Phase
Recruiting NCT03754725 - Ferritin and Iron Burden in SAH sIRB Phase 1/Phase 2
Completed NCT01556620 - Is NIRS Able to Detect Ischemia Following Brain Insult N/A
Completed NCT01832389 - Goal Directed Therapy After Aneurysmal Subarachnoid Haemorrhage N/A
Completed NCT04988932 - Inhaled Nitric Oxide Treatment for Aneurysmal SAH Patients With Intractable Cerebral Vasospasm N/A
Terminated NCT01343537 - Continuous Neurophysiological Monitoring Detection of Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage Subjects Phase 0
Completed NCT01569100 - Atorvastatin After Aneurysmal Subarachnoid Hemorrhage N/A